Cerity Partners’s Acceleron Pharma XLRN Stock Holding History

Cerity Partners’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,466	Closed	-$252K	–	1055
2021 Q3	$252K	Buy	+1,466	New	+$192K	0.01%	600

Cerity Partners's XLRN Position: Q4 2021 in Review

Cerity Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,466 shares — an estimated $252K sold.

Cerity Partners first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $252K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Cerity Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Cerity Partners sold 1,466 Acceleron Pharma shares in Q4 2021, an estimated $252K.
Cerity Partners first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Cerity Partners's Acceleron Pharma position peaked at $252K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Cerity Partners's 13F filing for Q4 2021, filed 14 Feb 2022.